＜4259＞ ExaWizards 352 +14
Significant continued growth. It was announced that the “exaBase IR Assistant” of Exa Enterprise AI Co., Ltd., which is a group company, has been introduced to Tokai Tokyo Financial Holdings Co., Ltd. Tokai Tokyo FH promotes DX of the person in charge's business by utilizing business-specific generative AI in each department related to information disclosure, such as general shareholders' meeting management and IR, and aims to realize an information disclosure system with higher added value.
＜4073＞ G.C. Planning 652 +6
backlash. The company, which develops business based on the cashless payment package software “CARD CREW PLUS” developed in-house, announced that it will add a common point “V point” starting 2024/4/22 to cashless payment service handling payments and begin providing services. “V points” will be added, and payment ASP services will be provided to major food and beverage chains and distribution and retail businesses.
＜5242＞ Eyes 1981 +27
backlash. A business alliance has started with Geocode Co., Ltd., which develops the web marketing business. Geocode operates web magazines such as “SEO Magazine by GEOCODE,” and distributes various marketing information in article format to the main reader base, starting with those in charge of SEO, web advertising, and web production, and marketers in general.
＜3900＞ Cloud W 943 +46
Significant continued growth. AI Tech, which is a wholly owned subsidiary and develops the AI business, announced that it will launch the “CrowdWorks AI Dojo,” a reskilling service specializing in AI skills, starting today. The CrowdWorks AI Dojo is a face-to-face reskilling service that supports side job practices through the provision of AI skills, and they have prepared courses where you can learn “AI skills” that are in high demand at the largest crowdsourcing service “CrowdWorks.jp” in Japan, and aims to increase the amount of remuneration for workers.
＜4894＞ Qualips 5000 -30
The whereabouts. On 5/29, Osaka University announced that a doctor-led clinical trial for dilated heart disease, which is being researched and developed to add the efficacy of treatment using human iPS cell-derived cardiomyocyte sheets for ischemic heart disease, began, and Qualips provided cardiomyocyte sheets for the first case of transplantation. Research and development for dilated heart disease has been selected for the Reiwa 5 “Regenerative Medicine Practical Application Research Project” by the Japan Agency for Medical Research and Development (AMED). Since funds have flowed in due to expectations for success in the next-generation regenerative medicine field and it has skyrocketed every day, developments that are being sold in reaction have continued since the previous weekend.
＜3930＞ Hatena 731 -69
Plummeting. According to the financial results announced after the big closing on 5/31, ordinary profit and loss for the 3rd quarter (23/8/24 to 4/24) of the fiscal year ending 24/7 fell to a deficit of 0.13 billion yen (surplus of 140 million yen in the same period last year). Ordinary profit and loss for the February-April fiscal year, which is the record for the last 3 months, also fell to a deficit of 0.44 million yen (surplus of 0.46 million yen in the same period last year), and the sales operating profit and loss ratio deteriorated from 5.6% in the same period last year to -7.4%.